(CVSB) Morgan Stanley Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US61774R6018
CVSB: Fixed, Variable, Floating-Rate Securities
The Morgan Stanley ETF Trust - Calvert Ultra Short Investment Grade ETF (CVSB) is an actively managed exchange-traded fund that focuses on investing at least 80% of its net assets in a diversified portfolio of high-quality, short-term fixed-income securities, including variable and floating-rate instruments. This investment strategy is designed to provide liquidity and preserve capital while generating returns that are less sensitive to interest rate fluctuations.
Given its ultrashort bond categorization, CVSB is likely to maintain a low duration, making it less vulnerable to changes in interest rates compared to longer-duration bond funds. The funds investment grade focus ensures that it invests in securities with high credit quality, thereby minimizing the risk of default. The active management approach allows the fund managers to dynamically adjust the portfolio in response to market conditions, potentially capitalizing on opportunities and mitigating risks.
Analyzing the provided
Combining insights from
Forecasting CVSBs performance based on the available data, we can infer that its stable short-term trend, coupled with its low volatility and high credit quality investments, positions it well for continued stability. If interest rates remain steady or decrease slightly, CVSB could potentially maintain its current price levels or experience modest growth, driven by its yield advantage relative to other low-risk investments. However, a significant shift in interest rates or a deterioration in credit markets could impact its performance. Therefore, a cautious outlook suggests that CVSB might hover around its current price or see a slight increase, assuming no major macroeconomic shifts.
Additional Sources for CVSB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CVSB ETF Overview
Market Cap in USD | 175m |
Category | Ultrashort Bond |
TER | 0.24% |
IPO / Inception | 2023-01-30 |
CVSB ETF Ratings
Growth Rating | 58.9 |
Fundamental | - |
Dividend Rating | 43.4 |
Rel. Strength | 9.33 |
Analysts | - |
Fair Price Momentum | 51.01 USD |
Fair Price DCF | - |
CVSB Dividends
Dividend Yield 12m | 4.99% |
Yield on Cost 5y | 5.65% |
Annual Growth 5y | 2.28% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CVSB Growth Ratios
Growth Correlation 3m | 96.7% |
Growth Correlation 12m | 99.7% |
Growth Correlation 5y | 100% |
CAGR 5y | 5.85% |
CAGR/Max DD 5y | 9.33 |
Sharpe Ratio 12m | 0.95 |
Alpha | 1.34 |
Beta | 0.002 |
Volatility | 2.24% |
Current Volume | 10.9k |
Average Volume 20d | 7.5k |
As of June 25, 2025, the stock is trading at USD 50.83 with a total of 10,875 shares traded.
Over the past week, the price has changed by +0.01%, over one month by +0.45%, over three months by +1.35% and over the past year by +5.56%.
Partly, yes. Based on ValueRay´s Analyses, Morgan Stanley Trust (NYSE ARCA:CVSB) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.94 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CVSB is around 51.01 USD . This means that CVSB is currently overvalued and has a potential downside of 0.35%.
Morgan Stanley Trust has no consensus analysts rating.
According to our own proprietary Forecast Model, CVSB Morgan Stanley Trust will be worth about 55.1 in June 2026. The stock is currently trading at 50.83. This means that the stock has a potential upside of +8.38%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 55.1 | 8.4% |